Merck Completes Acquisition of Verona Pharma
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Merck & Co. (NYSE: MRK) | Delayed: 152.78 +2.90 (1.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $149.88 | 52 Week High | $65.46 | |||
| Open | $151.05 | 52 Week Low | $47.97 | |||
| Day High | $153.30 | P/E | 103.93 | |||
| Day Low | $149.63 | EPS | $1.47 | |||
| Volume | 2,080,641 | |||||
| (NASDAQ: VRNA) | Delayed: 106.91 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $106.91 | 52 Week High | $ | |||
| Open | $106.91 | 52 Week Low | $ | |||
| Day High | $106.91 | P/E | N/A | |||
| Day Low | $106.91 | EPS | $ | |||
| Volume | 159,006 | |||||
